Form 483

Newton Laboratories, Inc. Form 483, 2018-03-30

FDA issued a Form 483 to Newton Laboratories, Inc. on 2018-03-30 with 8 public-safe observations.

483· Form 483 issuedHuman Drugs8 observations

Newton Laboratories, Inc. · Conyers, United States · Issued March 30, 2018

Overview

  • 8 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

30 Mar 2018
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Rachael L Cook, Susan O Oladeji

30 Mar 2018
21 CFR 211.196

Distribution Record Requirements

Cited by Rachael L Cook, Susan O Oladeji

30 Mar 2018
21 CFR 211.198(b)(3)

Reason for Not Conducting Complaint Investigation

Cited by Rachael L Cook, Susan O Oladeji

30 Mar 2018
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Rachael L Cook, Susan O Oladeji

30 Mar 2018
21 CFR 211.67(b)

Written procedures fail to include

Cited by Rachael L Cook, Susan O Oladeji

Inspected site

NLNewton Laboratories, Inc.Conyers, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.188Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.196Cited across public-safe Form 483 observations1x
21 CFR 211.198(b)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 8 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere